Total Funding
49
13
Total FundingGrant raised
Growth Score
-4 pts
Heat Score
-10 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
298850
LayerBio develops a proprietary LayerForm drug delivery technology for application in ophthalmology.
Kenneth Mandell: CEO & DirectorPast Role: Noveome Biotherapeutics, Chief Medical Officer
Paula T. Hammond: Director & Co-Founder
About the Company
LayerBio is developing novel drug delivery solutions to unmet medical needs in wound care, orthopedics and other therapeutic areas. Its unique LayerForm technology is based on propriety layer-by-layer (LbL) fabrication techniques developed at Massachusetts Institute of Technology (MIT).
It was founded in 2013 and is headquartered in Arlington,
Massachusetts.
Women Founded
